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Summary.-Eight patients with angioimmunoblastic lymphadenopathy have been
studied by a variety of immunological and pathological techniques. They exhibited a
spectrum of immunological reactivities that, in this small series, could be roughly
correlated with survival. Those patients with relative B-cell predominance as shown
by cell marker studies, histologically showed large numbers of plasma cells, and
this pattern was associated in 3 of our patients with a survival of 3 years or more.
T-cell predominance or both B- and T-cell depletion was associated histologically
with large numbers of blast cells and eosinophils, but with few plasma cells. These
patients responded poorly to therapy and had short survival times. One patient with
B-cell predominance subsequently died of a histiocytic lymphoma.
IN 1975 Lukes and Tindle described 32
patients with lymphadenopathy histo-
logically characterized by a proliferation of
arborizing small vessels, prominent im-
munoblastic hyperplasia and amorphous
acidophilic, PAS+, interstitial material.
They designated this condition as immuno-
blastic lymphadenopathy, and proposed
that it developed as a non-neoplastic
hyperimmune proliferation of the B-cell
system, involving an exaggeration of
lymphocyte transformation to lympho-
blasts and plasma cells, triggered by an
abnormal hypersensitivity response to
therapeutic agents. In 3 of their patients
the process evolved into an immunoblastic
sarcoma. Frizzera et al. (1975) described
24 patients with a syndrome characterized
clinically by severe constitutional symp-
toms, generalized lymphadenopathy,
hepatosplenomegaly and polyclonal hyper-
gammaglobulinaemia and with histo-
pathological features similar to those
described by Lukes and Tindle. They
designated this condition as angioimmuno-
blastic lymphadenopathy with dyspro-
teinaemia (AILD) and proposed that the
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various manifestations of this conidition
are consistent with an autoimmune dis-
order in which a deficiency of the T-cell
regulatory function predisposes to an
abnormal proliferation of autoaggressive
B lymphocytes. None of their patients
progressed to lymphoma. It is probably
that this entity is the same as that des-
cribed by Lukes and Tindle, or at least
that there is a considerable overlap in the
2 series.
We have recently seen 8 patients with
angioimmunoblastic lymphadenopathy
and have been able to undertake immuno-
logical studies on fresh lymphnode
material from 5 of these. The results pre-
sented reveal an immunological hetero-
geneity correlated with histological
features, reflecting either the evolution of
the disease with time or the inclusion of
spectrum of reactivities in this condition.
MATERIALS AND METHODS
Patients.-Seven of the patients were seen
in hospitals in the Southampton District
during the period 1973-77 and diagnosed on
routine lymphnode biopsy for the investiga-11). B. JONES E'T AL.
tion of lymnphadenopathy. One patient wNas
originally diagnosed as mixed-cellularity
Hodgkin's disease in 1972, and was identified
as AIL in 1976 when his original histological
sections Awere reviewed.
Repeat lymphnode biopsies Aere obtained
fresh from 5 of the 8 patients. Paraffin-
embedded sections wN-ere stained by haema-
toxylin and eosin, PAS, methyl green pyronin
and Gordon and Sweet's reticulin technique
for histological examination.
Cell suspensions.-Fresh lymphnode
material was finely minced and teased in cold
HEPES-buffered RPMI 1640 (Flowr Labora-
tories, Irvine, Scotland), filtered through
gauze and layered over Ficoll-Triosil (Thorshy
and Bratilie, 1970). Cells collected at the
interface were washed x 3 in cold medium
and the final pellet resuspended at 2 x 106
cells/ml in HEPES-buffered medium for cell-
surface marker-studies. Peripheral-blood
lymphocytes were similarly prepared from
venous blood by centrifugation through
Ficoll-Triosil.
Rosette tests. Viable mononuclear cell
preparations were examined for T lympho-
cytes by spontaneous sheep-cell rosetting, and
for the presence of receptors for C3 and the
Fc portion of Ig by rosetting with appro-
priately sensitized ox red blood cells. Cell
suspensions AN-ere further stained with a poly-
valent rabbit antiserum to human immuno-
globulin heavy chains and to K and A light
chains. Full details of these tests have been
published previously (Payne et al., 1976).
Immunoperoxidase technique.- For the
demonstration of intracellular immunoglobu-
lins the unlabelled antibody/enzyme method
(PAP) wasperformedon5yim paraffinsections,
using the basic technique described by Burns
(1975) following treatment with 0-1% trypsin
(Huang et al., 1976) after blocking endogenous
peroxidase activity with methanol/H202.
Rabbit antiserum to human A G M D E heavy
chains and K and A light chains (Hoechst
Pharmaceuticals, Hounslow), rabbit anti-
human muramidase (lysozyme), swine anti-
rabbit IgG and PAP (Dako; agents Mercia
Diagnostics, Watford, Herts) w-ere titrated on
control sections and used at their respective
optimum titres. Specificity of antisera was
established using radial immunodiffusion and
immunoelectrophoretic techniques. The re-
placement of antisera with non-immune
rabbit serum and a slide treated w%ith diamino-
benzidine reagent alone served as controls.
Electron microscopy.-Tissue from 5 cases
was processed for electron microscopy, either
by immediate fixation in 40o gluteraldehyde
in cacodylate buffer at pH 7-2 or by transfer
from 10% buffered formol saline to gluter-
aldehyde for 24 h. Tissue was post-fixed in
osmium tetroxide, embedded in Spurr resin
and sectioned on a Reichert OMU3 ultra-
microtome. Thin sections wvere stained wxith
lead citrate/uranyl acetate and examined in a
Phillips 201 electron microscope.
Cytogenetics.-Cytogenetic analysis wvas
performed on dispersed lymphnode cells at
the Regional Cytology Laboratory by Dr M.
Seabright.
RESULTS
(a) Marker stutdies
The results of lymphocyte marker
studies performed on viable cells dispersed
from lymphnode biopsy material from 5
patients with AIL are presented in Table
II. By comparison with control values
these patients appear to form a hetero-
geneous group exhibiting either relative
T-cell predominance (ID, HK) relative
B-cell predominance (RM, JP) or an
apparent depletion of both lymphocyte
subsets (RF).
All patients were lymphopenic at presen-
tation or became so during the course of
their disease. In 3 patients (HK, FP, RF)
the relative percentage of T lymphocytes
in the peripheral blood measured by
spontaneous sheep-erythrocyte rosetting
was below the normal range. With
advancing disease and treatment all
patients showed a decline in T-cell per-
centages.
(b) Serunt studies
A polyclonal elevation in serum im-
munoglobulin was observed in 3 patients
(ID, RM, JP) an increase not confined to
anysingleimmunoglobulin class (Table II).
In all patients serum immunoglobulin
levels declined with advancing disease.
Urinary paraproteins were not detected
in any of the 8 patients studied. Auto-
antibody activity; directed to thryoid
microsomes was detected in only one
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TABLE I.-Clinical Features at Presentation
Hepatomegaly Splenomegaly Skin rash
+
+
+
Fever
T~
+
+
TABLE II.-Surface Marker and Immunochemical Data in AIL
% Lymphs
Lym phs/I
(x 109) T Ig B/Fc C3
74 10 7 2
0-53 59 12 -
68 4 9 6
0 9 47 25 21
28
68
3
66
nd
(25
±13)
(20
±5)
44
36
16
39
74
nd
(9
±7)
(25
± 10)
(mean ±range)
60
63
18
14
69
nd
(43
±12)
(25
± 10)
ilLN -
BL 0-9 0 -27 45
LN 37
BL nd nd
LN - 35
BL 4-0 1-8 32
LN 21
BL nd nd 62
LN - (54
+ 12)
BL (3-9) (1-3) (60
(limits) ± 10)
+
Serum immuno-
chemistry (g/l)
-A
G A M
11-2 0-6 2-5*
6-6 2-4 0-8
10-2 3-8 0 4
19-7* 3 4 2-8*
6-4 2-4 1-5
19-8* 4-6* 0-60
(7 0 (1-2
-13-0) -3-5)
(limits)
(0-4
-1 - 3)
t BL = Venous Blood taken at presentation.
LN = Viable Lymphnode Cell preparations.
= Levels significantly raised.
patient (ID) and this patient also exhibited
a positive indirect Coomb's test.
(c) Histopathological correlations
Marker studies performed on fresh
biopsy material correlated with the histo-
logical appearance of the lymph nodes
(Table III). Patients with a high ratio of
T to B cells or T- and B-cell depletion
(ID, HK, RF) showed prominent arboris-
ing blood vessels, numerous eosinophils,
blast cell proliferation but few plasma-
blasts orplasma cells (Fig. 1 and 2) whereas
patients with a high B/T ratio (RM, JP)
showed marked plasma-cell and plasma-
blast proliferation but few or no eosino-
phils (Fig. 3, 4, 5 and 6).
(d) Immunoperoxidase
The immunoperoxidase findings paral-
leled the histological appearances and
marker studies (Table III) in that the 2
patients with B-cell predominance showed
large numbers of immunoglobulin con-
taining plasma cells and plasmablasts of
all classes including a moderate number of
cells staining for IgD and IgE (Fig. 3 and
4). One of the patients on whom marker
studies were not done showed large
numbers of Ig-containing cells and the
other, moderate numbers. IgG+ cells were
most frequent, followedbyIgA+and IgM+.
In 3 patients (ID, FP, RP) staining with
anti-IgE and anti-light-chain sera showed
a focal reticular pattern of staining
Patient
SH
ID
HK
FP
RM
RF
RP
JP
Age/sex
29/M
46/F
55/M
61/M
66/M
71/M
76/M
84/M
Lymphadeno-
pathy
+
+
+
+
Speciment
LN
BL
LN
BL
T 1WT
WBC/I
(x 109)
7-5
5-5
Patient
ID
HK
FP
RM
RF
JP
formal
values
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FIG. 1.-Lymphnode section with immuno- FIG. 2.-As in Fig. 1. x 280.
peroxidase stain to demonstrate IgM in
T-cell-predominant case of AIL (ID).
Haematoxylin counter stain, x 110.
TABLE III.-Relationship between Cell Markers, Histological Features, Immunoglobulin
Profile and Survival
Histological features
Blood vessel PAS+
Cell markers Patient proliferation material
Blast Plasma Eosino- Ig+
cells cells phils cells*
T-cell Pre-
dominance
B-cell Depletion
B-cell Pre-
dominance
T-cell Depletion
HK
ID
±+
±±+ +
- ±+ + 10months
- + + + 13 months
RM ++ ++ + - +++ 3iyears
Histiocytic
lymphoma Jp ++ + + +++ - +++ 7months
T- and B-cell RF + - + +
Depletion FP + + + +
No marker
studies
RP ++ - +
SH + - +
* Demonstrated by immunoperoxidase technique.
- i 13 months
+ + + I month
+ - ++ + Alive after
5 years
+ + Alive after
4 years
Survival
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FIG. 3. Lymph node section with immuno-
peroxidase stain to demonstrate IgM in
B-cell-predominant case of AIL (JP).
Haematoxylin counter stain, x 110.
similar to that seen in some germinal
follicles, but in these instances not associ-
ated with recognizable residual follicles
(Fig. 7).
(e) Karyotypic studies
In 3 patients (ID, FP, RF) where
satisfactory cell preparations were ob-
tained, abnormal cell clones were observed
(Table IV). No consistent chromosomal
abnormality was identified. In one patient
(RF) an abnormal population identified
TABLE IV.-Cytogenetic Analyysis in 3
Cases of AIL
Patient
ID
FP
RF
Karyotype
Abnormal clone with 48 chromosomes
(extra X, 5, 19)
Abnormal clone with 48 chromosomes
Abnormal population with marker No. 3
chromosome in lymphnode and ascitic
fluid
44
FIG. 4. As in Fig. 3, x 280. Note positive
staining of mature plasma cells and also of
plasmablasts with visible nucleoli.
initially in the lymphnode was later
observed in ascitic fluid.
(f) Electron microscopy
Electron-microscopic studies supported
the light-microscopic findings but other-
wise contributed nothing. Virus particles
or other abnormal inclusions were not seen
in any of the cases studied.
(g) Clinical correlations
This series of patients exhibited no
common clinical features prior to the
identification of lymphadenopathy; one
patient had a tooth abscess, one a "flu-
like" illness, one had serological evidence
of a recent cytomegalovirus infection and
3 were receiving a variety ofdrugs shortly
before the onset oftheir disease.
Six of the patients have died, 5 within
13 months on onset and one after 40
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FIG. 5.-Spurr-embedded I,m section of AIL FIG. 6.-As Fig. 5, x 1100. Note plasma cells
Lymphnode (JP). Note arborizing blood and plasmablast (arrow) with strands of
vessels with plump endothelial cells and rough endoplasmic reticulum visible in
numerous plasma cells. Toluidine blue, cytoplasm.
x280.
TABLE V.-Post Mortem Findings
Lymphnodes Spleen
Inguinal and abdominal Enlarged.
nodes enlarged. Cords congested.
AIL tissue. AIL tissue.
Liver
Enlarged.
Non-specific changes.
Others
Ulcerated palate due to
AIL tissue. Generalized
herpes zoster skin rash.
HK Generalized moderate
enlargement.
Almost acellular.
183 g.
Areas of acellular
necrosis.
FP Generalized moderate 1865 g.
to marked enlargement. Small infarcts.
AIL tissue. AIL tissue.
RF Massive generalized
enlargement.
AIL tissue.
1357 g.
Cords congested.
AIL tissue.
RM Small sinus histiocytosis 300 g.
occasional tumour cells Diffusely infiltrated
by histiocytic
lymphoma.
1565 g.
Cholestatis.
Mild centrilobular liver
cell necrosis.
3111 g.
Portal infiltrations.
AIL tissue.
1641 g.
Portal infiltrates.
AIL tissue.
Organizing portal-vein
thrombosis.
1850 g.
Portal triads expanded
by tumour cell
infiltrates.
Anaemia.
Bronchopneumonia.
Bronchopneumonia.
Histiocytic lymphoma
infiltration of myo-
cardium, lung and
kidneys.
Patient
ID
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FIG. 7. Lymphnode section with immuno- FIG. 8. Spurr-embedded Il m section of
peroxidase stain to demonstrate IgE (RP). heart from patient with histiocytic lym-
Deposition of stain in a reticular fashion phoma (RM). Note diffuse infiltration of
around bloodvessel. Haematoxylin counter pleomorphic tumour cells between myo-
stain, x II0. fibres. Toluidine blue, x 280.
months with widespread lymphoma, diag-
nosed histologically and by the immuno-
peroxidase technique (tumour cells mur-
amidase+) as being a true histiocytic
lymphoma (Fig. 8 and 9). The 2 patients
with T-cell predominance both had a
stormy fluctuating clinical course, with
death from infection at 10 and 13 months
post presentation. The 2 cases from whom
viable biopsy material was not available
for marker studies, both showed a histo-
logical pattern associated with B-cell
predominance, and both are alive at 4 and
5 years after presentation. The post
mortem findings are presented in Table V.
DISCUSSION
It is probable that, before 1975 when
Lukes and Tindle and Frizzera et al.,
described the condition now recognized as
angioimmunoblastic lymphadenopathy,
most of these patients were diagnosed as
Hodgkin's disease. Lukes and Tindle
suggested that AIL may be induced by
therapeutic agents, and it is possible that
we are witnessing a new disease or a
greatly increased incidence ofAIL. In this
series we have been unable to identify any
therapeutic agent common to all the
patients. Frizzera et al. (1974; 1975) have
argued that AIL can be separated from
malignant lymphoma by the polymorphic
nature of the lesion, the absence of
pleomorphism, and the fact that visceral
masses and diffuse organ infiltrates are not
seen in patients at post mortem. We would
stress the widespread nature of the
lymphadenopathy, often with enormous
enlargement of all lymphnode groups, the
often explosive onset of the disease, and
the rapid fluctuations of the lymphadeno-
pathy, as features that are unusual in most
1059D. B. JONES ET AL.
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FiG. 9. Part Figure 8, x 1100, showing
phagocytosis by tumour cells (arrow).
malignant lymphomas. However, the
clinical picture is clearly not in itself
diagnostic and laboratory confirmation is
required.
Polyclonal hypergammaglobulinaemia
present in 17/22 cases described by
Frizzera et al. (1974) was found in only
3/6 patients in this series. We noted a
substantial fall in the serum Ig in all
patients with disease progression, suggest-
ing that the inconstancy of this feature
may be related to the duration and stage
of the disease at presentation. The defini-
tive diagnosis of AIL depends upon
histological examination of involved
lymphoid tissue. Lukes and Tindle (1975)
described a diagnostic triad of immuno-
blast and plasma-cell hyperplasia, pro-
liferation of small arborizing blood vessels
and the presence of amorphous extra-
' ~~~~~~~~~
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FIG. 10. Lymphnode section with immuno-
peroxidase stain to demonstrate murami-
dase (RP) showing dark-staining eosino-
phils and dendritic histiocytes. Haemato-
xylin counter stain, x 280.
cellular PAS+ material. The latter was an
inconstant finding in this series (Table IV)
and was abundant in only 6/24 patients
reported by Frizzera et al. (1975). Palutke
et al. (1976) identified this material in
electron micrographs as necrotic cell
debris. It is perhaps not surprising, there-
fore, that this is a variable feature.
Vascular proliferation is a feature of
lymph nodes in infectious mononucleosis
(Carter and Penman, 1969) post-vaccinial
lymphadenitis (Hartsock, 1968) congenital
rubella (Krueger and Konorza, 1977) and
in many lymphnodes showing non-
specific reactive hyperplasia. In AIL the
arborizing nature ofthe vascular prolifera-
tion (Fig. 5) is usually much more evident
than in these reactive and infective con-
ditions, and is associated with total or
almost complete effacement of the normal
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nodal architecture. In this series of
patients, arborizing bolod vessels were
least well developed in patients with B-cell
predominance. Sidky and Aurbach (1975)
described vascular proliferation as a
measure of immune reactivity to auto-
antigens, and it would seem reasonable to
propose that T-cell reactivityisresponsible
for the vessel proliferation seen in AIL.
Palutke et al. (1976) described tubular
inclusion in endothelial cells and lympho-
cytes from one patient with AIL studied
by electron microscopy. We have not seen
virus-like inclusions in any of the 4 cases
studied by direct electron-microscopy, nor
in endothelial cells from a 3-week culture
oftissue from one case (ID).
We used marker techniques to study the
lymphoid cells in AIL. Within this small
group of patients, lymphocyte marker
studies indicate a marked heterogeneity in
lymphnode populations that correlates
with the immunoperoxidase studies and
the histological appearances, and may
have prognostic significance. Relative B-
cell predominance is accompanied histo-
logically by plasmablast and plasma-cell
proliferation, a picture that in this series
was indicative of a relatively good prog-
nosis. Patientswithblast-cell proliferation,
abundant eosinophils but few plasma cells,
the histological picture associated with
T-cell predominance or B- and T-cell
depletion, had a poorer prognosis. We did
not observe transition from B-cell pre-
dominance to T-cell predominance in any
of the patients, suggesting that these are
not separate phases within a single disease
spectrum.
The association of relative B-cell pre-
dominance, as shown by marker studies,
with plasma-cell proliferation, was con-
firmed by the immunoperoxidase studies,
which showed numerous plasma cells and
plasmablasts ofall classesinthese patients.
Many fewer immunoglobulin-containing
cells were seen in the T-cell predominant or
T- and B-cell depleted groups. We are
uncertain of the significance ofthe patchy
reticular distributionofIgEandbothlight-
chain classes in 3 of the cases (Fig. 7). A
similar pattern is seen in some germinal
follicles of reactive lymphnodes, and was
first described by Tada and Ishizaka
(1970) using fluorescein-conjugated anti-
sera. In the patients with AIL there were
no residual follicles recognizable in the
areas showing this IgE staining. In
addition to large numbers of eosinophils,
in some cases the immunoperoxidase stain
for muramidase also showed large numbers
of histiocytes (Fig. 10). The number of
histiocytes did not appear to differ
significantly between the 2 groups. Many
had a rounded cell outline though some
were dendritic, and some of these also
stained for IgG and light chains. This
immunoglobulin had presumably been
taken up from the surrounding tissue
fluid.
Hossfield et al. (1976) have reported
cytogenetic abnormalities in lymphnode
chromosome preparations from 2 patients
with AIL. We have found cytogenetic
abnormalities, with subpopulations bear-
ing marker chromosomes, in the lymph-
nodes of the 3 patients from whom we
obtained satisfactory preparations. There
was no common feature shared by these
cases, and it is difficult to know what
interpretation to place on this observation.
It would clearly be of interest to know
whether the abnormalities are present in
T cells, B cells or macrophages, and in
future studies we will carry out our
analyses on separated cell populations.
Of the 32 cases of AIL reported by
Lukes and Tindle (1975), 3 subsequently
developed immunoblastic sarcomas. Don-
huijsen et al. (1977) reported 3 patients
with AIL terminating as malignant
lymphomas, and noted that 13 such
transitions have now been described.
Malignant lymphoma developed in one of
the patients in this series (RM). At post-
mortem the tumour showed widespread
infiltration of heart and lungs, with
relative sparing of the small residual
lymphnodes. The histological appearance
of the tumour was consistent with true
histiocytic lymphoma, which was con-
firmed by the presence of phagocytosed
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material and positive cytoplasmic staining
for muramidase and polyclonal immuno-
globulins by the immunoperoxidase
technique.
With the exception of one case of
Hodgkin's disease (Yatanagas et al., 1977)
all tumours previously described as ter-
minations of AIL have been of B-cell
lineage, possibleoccurringasaconsequence
of B-cell hyperstimulation and/or lack of
T-cell regulatory function. The presence in
our series of a tumour of histiocytic origin
suggests that a more generalized disturb-
ance of the immune system may underlie
the termination ofAIL in malignancy. It is
possibly significant that 6 months after
one of our patients (SH) presented with
AIL his brother developed nodular scler-
osing Hodgkin's disease.
The patients in this series who have died
have all shown widespread intercurrent
infection associated with a decline in
all measured immunological parameters.
Frizzera et al. (1975) similarly noted
immunodeficiency with death from inter-
current infection in several of their
patients, and they warned of the danger
of hastening this process by treatment
with immunosuppressive cytotoxic agents.
This poses atherapeutic dilemma, since the
only patients in this series who became
long-term survivors were treated with
cytotoxic drugs, and in none did we see
more than a transient response to steroids.
The infrequency of AIL makes it difficult
forone centre to acquireenough experience
to determine the optimal therapy for this
condition, and there would appear to be a
good case for instituting a national trial or
for incorporating these patients into one
of the existing lymphoma trials. The
findings of this small series suggests that
AIL can be divided into 2 immunopatho-
logical categories, and that these are
associated with differences in clinical
behaviour. It will be of interest to see
whether further cases and larger series
confirm these observations.
We are grateful to Mrs M. Ventham for secretarial
assistance. Professor D. H. Wright is in receipt of a
research grant from the Cancer Research Campaign.
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